Cargando…
Editorial: Use of 3D Models in Drug Development and Precision Medicine - Advances and Outlook
Autores principales: | Prina-Mello, Adriele, Bonacina, Luigi, Staedler, Davide, Movia, Dania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7965946/ https://www.ncbi.nlm.nih.gov/pubmed/33748095 http://dx.doi.org/10.3389/fbioe.2021.658941 |
Ejemplares similares
-
In vitro Alternatives to Acute Inhalation Toxicity Studies in Animal Models—A Perspective
por: Movia, Dania, et al.
Publicado: (2020) -
Preclinical Development of Orally Inhaled Drugs (OIDs)—Are Animal Models Predictive or Shall We Move Towards In Vitro Non-Animal Models?
por: Movia, Dania, et al.
Publicado: (2020) -
ALI multilayered co-cultures mimic biochemical mechanisms of the cancer cell-fibroblast cross-talk involved in NSCLC MultiDrug Resistance
por: Movia, Dania, et al.
Publicado: (2019) -
Three-dimensional (3D) liver cell models - a tool for bridging the gap between animal studies and clinical trials when screening liver accumulation and toxicity of nanobiomaterials
por: Tutty, Melissa Anne, et al.
Publicado: (2022) -
Multilayered Cultures of NSCLC cells grown at the Air-Liquid Interface allow the efficacy testing of inhaled anti-cancer drugs
por: Movia, Dania, et al.
Publicado: (2018)